The smart supply chain is efficient, automatic, safe and traceable. It is able to uniquely identify the drug in order to guarantee its path and verify compliance with storage conditions. Within it, the different processes dialogue with each other and define an environment in which critical issues are identified and governed, activating solutions capable of preventing and mitigating risks. In this context, it becomes possible to ensure compliance with the legislation and, consequently, dispensability to the patient.
Our CEO Alberto Bartolini, Coordinator of the Supply Chain and Innovation Area AFI – ASSOCIAZIONE FARMACEUTICI INDUSTRIA, spoke about traceability and data management in his speech on “The intelligent supply chain: strengths and weaknesses” on the occasion of “Pharma ex machina: the world of health between human and artificial”, an event organized by NCF – Notiziario Chimico Farmaceutico, of which Bartolini himself is Scientific Director.
The speech highlighted the central role of the transposition of the contents of Directive (EU) 2011/62 as a tool aimed at ensuring traceability, a fundamental aspect in particular for Cold Chain medicines. The need for further efforts to ensure truly continuous traceability of the drug along the entire supply chain is underlined, through the implementation of digitized processes that guarantee data integrity and in which AI becomes a tool for optimizing the integrated processes of the individual players in the supply chain.





